ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Teva proposes to buy Mylan for $40.1 billion
biospectrumasia
November 16, 2018He added that Mylan's business is a natural fit with Teva and is highly complementary to it. Merging the two companies would not only deliver the greatest value
Pharma Sources Insight January 2025
